By Sougato Das, President and COO, LSN

Securing investment is rarely about delivering the perfect pitch. Successful fundraising is built on understanding how investors evaluate opportunities, developing meaningful relationships, and communicating a compelling value proposition that stands up to diligence.

On Thursday, July 9, at 12:00 PM ET, Life Science Nation will bring together an outstanding panel of active life science investors for an in-depth discussion on what it takes to raise capital in today’s investment environment. The webinar will feature George Voren, VP of Founder Strategy and Operations at Curie.Bio; Yaniv Sneor, Founder of Mid Atlantic Bio Angels; Anna Crespo Puig, Investment Analyst at AdBio Partners; and Ankita Das, Senior Venture Development Associate, Therapeutics, at NLC Health Ventures. Together, they represent a diverse range of investment perspectives spanning venture creation, angel investing, venture capital, and strategic venture development.

George Voren Curie.Bio	Yaniv Sneor Mid Atlantic Bio Angels
Anna Crespo Puig AdBio Partners	Ankita Das NLC Health Ventures

Moderated by Life Science Nation, the conversation is designed to deliver actionable insights for entrepreneurs preparing to raise capital, whether they are beginning their fundraising journey or actively engaging investors.

As market conditions continue to evolve, founders are navigating an increasingly competitive fundraising landscape. This webinar will provide practical guidance on how investors are approaching new opportunities, what they expect to see in executive summaries and pitch decks, how entrepreneurs can secure productive investor meetings both inside and outside partnering conferences, and the common mistakes that can derail an otherwise promising opportunity. The panel will also discuss what founders should expect once discussions move beyond a confidentiality agreement and into deeper diligence.

Reserve your spot today and join Life Science Nation on July 9 at 12:00 PM ET for this timely discussion.

Sign Up for the Investor Webinar

By Sougato Das, President and COO, LSN

As RESI San Diego approaches, Life Science Nation has been helping founders and executives prepare for investor conversations through a three-part webinar series focused on one of the most important challenges in life science fundraising: transforming strong science into a compelling investment opportunity.

The first two sessions in the series explored why many promising companies struggle to attract capital despite strong technology and how founders can better communicate risk reduction, investment readiness, and strategic value to investors.

Webinar Recording: De-Risking, Shaping, and Micro-Investment

In this session, Rick Berenson, partner to Dennis Ford in the Anchor Node project and co-author of Dissecting Return and Risk: A Framework for Financing Life Science Startups, examined how investors evaluate risk across early-stage companies and why scientific promise alone is rarely enough to secure funding.

The discussion explored the role of micro-investment as an early filtering mechanism, the importance of systematically reducing risk across the development pathway, and how founders can shape scientific assets into investable opportunities capable of attracting institutional capital.

---

Webinar Recording: From Pitch Deck to De-Risk Deck

Dennis Ford, Founder and CEO of Life Science Nation, challenged the traditional approach to fundraising presentations by introducing the concept of the “de-risk deck.”

The webinar explored why investors focus on evidence of risk reduction rather than vision alone and why capital flows toward companies that clearly communicate scientific, regulatory, execution, and commercialization progress. Dennis also discussed investor targeting, outreach strategy, and the realities of navigating a successful life science fundraising campaign.

---

Final Webinar: Science to Signal

June 18, 2026 | 1:00 PM ET

The webinar series concludes this Thursday with Science to Signal, presented by Max Braht and Karen Deyo.

This session introduces the Science to Signal framework, a practical system designed to help life science startups translate scientific achievements into clear investment signals. Attendees will learn how the framework aligns development strategy with investor risk assessment, supports enterprise implementation within incubators and innovation programs, and helps founders better communicate progress to potential investors and partners.

Register for Science to Signal

Whether you are actively fundraising, preparing for partnering meetings, or refining your investment story, this webinar series provides practical frameworks for improving investor engagement and positioning your company for more productive capital formation discussions.

Register for RESI San Diego